Variant report
Variant | esv18894 |
---|---|
Chromosome Location | chr5:151843033-151846488 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs188362657 | chr5:151843061-151843062 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs554913107 | chr5:151843072-151843073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs536674335 | chr5:151843077-151843078 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs72793460 | chr5:151843104-151843105 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs534899610 | chr5:151843146-151843147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs552919438 | chr5:151843190-151843191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs7700695 | chr5:151843206-151843207 | Flanking Active TSS Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs150652541 | chr5:151843227-151843228 | Flanking Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs569327648 | chr5:151843245-151843246 | Flanking Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs36115811 | chr5:151843253-151843254 | Flanking Active TSS Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs181271000 | chr5:151843320-151843321 | Flanking Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs562048814 | chr5:151843378-151843379 | Flanking Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs577062790 | chr5:151843416-151843417 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs72793462 | chr5:151843439-151843440 | Active TSS Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs144854323 | chr5:151843456-151843457 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs185734434 | chr5:151843502-151843503 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs191514076 | chr5:151843503-151843504 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs72793463 | chr5:151843518-151843519 | Active TSS Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs147953205 | chr5:151843542-151843543 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs548600427 | chr5:151843615-151843616 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs567231347 | chr5:151843635-151843636 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs12658063 | chr5:151843659-151843660 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs370536803 | chr5:151843684-151843685 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs11744469 | chr5:151843695-151843696 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs546862805 | chr5:151843703-151843704 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs571410056 | chr5:151843718-151843719 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs534221873 | chr5:151843737-151843738 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs538860108 | chr5:151843739-151843740 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs557160937 | chr5:151843765-151843766 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs140155296 | chr5:151843781-151843782 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs558561214 | chr5:151843804-151843805 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs12655878 | chr5:151843817-151843818 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs12660058 | chr5:151843851-151843852 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs148034957 | chr5:151843939-151843940 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs573972017 | chr5:151843941-151843942 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs77081761 | chr5:151843942-151843943 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs62393528 | chr5:151844043-151844044 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs62393529 | chr5:151844052-151844053 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs187171768 | chr5:151844132-151844133 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs551074757 | chr5:151844140-151844141 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs548665133 | chr5:151844173-151844174 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs560761504 | chr5:151844180-151844181 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs62393530 | chr5:151844182-151844183 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs192468457 | chr5:151844222-151844223 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs182111451 | chr5:151844314-151844315 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs111578774 | chr5:151844327-151844328 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs186796231 | chr5:151844328-151844329 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs550823146 | chr5:151844355-151844356 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs537937262 | chr5:151844419-151844420 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs537586529 | chr5:151844462-151844463 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Hyperekplexia | 16941485 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Crohn''s disease | 20877625 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Breast cancer | 17603634 | CNVD |
Crohn''s disease | 20106866 | CNVD |
Breast cancer | 20409316 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Prostate cancer | 18632612 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:151840000-151846400 | Enhancers | Fetal Intestine Small | intestine |
2 | chr5:151841000-151843200 | Enhancers | Fetal Intestine Large | intestine |
3 | chr5:151842000-151846000 | Enhancers | Stomach Mucosa | stomach |
4 | chr5:151843000-151843200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr5:151843200-151843400 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr5:151843200-151844600 | Weak transcription | Fetal Intestine Large | intestine |
7 | chr5:151843400-151843600 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr5:151843600-151844600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr5:151844400-151845200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
10 | chr5:151844600-151845200 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr5:151844600-151846200 | Enhancers | Fetal Intestine Large | intestine |
12 | chr5:151845200-151845800 | Enhancers | Right Atrium | heart |
13 | chr5:151845200-151846200 | Enhancers | Adipose Nuclei | Adipose |
14 | chr5:151845200-151846400 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr5:151845400-151846400 | Enhancers | Left Ventricle | heart |
16 | chr5:151845800-151846000 | Enhancers | Brain Hippocampus Middle | brain |
17 | chr5:151845800-151846200 | Weak transcription | Right Atrium | heart |
18 | chr5:151846000-151851600 | Weak transcription | Brain Hippocampus Middle | brain |
19 | chr5:151846200-151846400 | Enhancers | Right Atrium | heart |
20 | chr5:151846400-151847000 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
21 | chr5:151846400-151850000 | Weak transcription | Right Atrium | heart |
22 | chr5:151846400-151851200 | Weak transcription | Left Ventricle | heart |